Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Zyprexa — ZYPREXA
Application NDA020592 (NDA)
Zyprexa — ZYPREXA ZYDIS
Application NDA021086 (NDA)
Zyprexa — ZYPREXA
Application NDA021253 (NDA)
Zyprexa — ZYPREXA RELPREVV
Application NDA022173 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)